Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia.
Decroocq J, Birsen R, Montersino C, Chaskar P, Mano J, Poulain L, Friedrich C, Alary AS, Guermouche H, Sahal A, Fouquet G, Gotanègre M, Simonetta F, Mouche S, Gestraud P, Lescure A, Del Nery E, Bosc C, Grenier A, Mazed F, Mondesir J, Chapuis N, Ho L, Boughalem A, Lelorc'h M, Gobeaux C, Fontenay M, Recher C, Vey N, Guillé A, Birnbaum D, Hermine O, Radford-Weiss I, Tsantoulis P, Collette Y, Castellano R, Sarry JE, Pasmant E, Bouscary D, Kosmider O, Tamburini J. Decroocq J, et al. Among authors: guille a. Leukemia. 2022 May;36(5):1237-1252. doi: 10.1038/s41375-022-01541-0. Epub 2022 Mar 30. Leukemia. 2022. PMID: 35354920 Free PMC article.
Signaling pathway switch in breast cancer.
Guille A, Chaffanet M, Birnbaum D. Guille A, et al. Cancer Cell Int. 2013 Jun 27;13(1):66. doi: 10.1186/1475-2867-13-66. Cancer Cell Int. 2013. PMID: 23805779 Free PMC article.
ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P, Guille A, Adelaide J, Birnbaum D, Chaffanet M, Bertucci F. Finetti P, et al. Among authors: guille a. Breast Cancer Res Treat. 2014 Aug;147(1):51-9. doi: 10.1007/s10549-014-3070-z. Epub 2014 Aug 3. Breast Cancer Res Treat. 2014. PMID: 25086634
Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
Collette Y, Prébet T, Goubard A, Adélaïde J, Castellano R, Carbuccia N, Garnier S, Guille A, Arnoulet C, Charbonier A, Mozziconacci MJ, Birnbaum D, Chaffanet M, Vey N. Collette Y, et al. Among authors: guille a. Blood Cancer J. 2015 Mar 13;5(3):e292. doi: 10.1038/bcj.2015.13. Blood Cancer J. 2015. PMID: 25768406 Free PMC article. No abstract available.
Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci F, Finetti P, Guille A, Adélaïde J, Garnier S, Carbuccia N, Monneur A, Charafe-Jauffret E, Goncalves A, Viens P, Birnbaum D, Chaffanet M. Bertucci F, et al. Among authors: guille a. Oncotarget. 2016 May 10;7(19):27208-19. doi: 10.18632/oncotarget.8349. Oncotarget. 2016. PMID: 27028851 Free PMC article.
Epigenetically centered evolution in an example of myeloid malignancy.
Adélaide J, Cervera N, Carbuccia N, Garnier S, Guille A, Mozziconnaci MJ, Devillier R, Chaffanet M, Vey N, Birnbaum D, Gelsi-Boyer V. Adélaide J, et al. Among authors: guille a. Am J Hematol. 2016 Sep;91(9):E361-2. doi: 10.1002/ajh.24450. Epub 2016 Jul 4. Am J Hematol. 2016. PMID: 27299509 Free article. No abstract available.
Genomic analysis of myeloproliferative neoplasms in chronic and acute phases.
Courtier F, Carbuccia N, Garnier S, Guille A, Adélaïde J, Cervera N, Gelsi-Boyer V, Mozziconacci MJ, Rey J, Vey N, Chaffanet M, Birnbaum D, Murati A. Courtier F, et al. Among authors: guille a. Haematologica. 2017 Jan;102(1):e11-e14. doi: 10.3324/haematol.2016.152363. Epub 2016 Oct 14. Haematologica. 2017. PMID: 27742771 Free PMC article. No abstract available.
69 results